Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target. Cancer Communications.
Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target. Cancer Communications.
复制标题
作者:
Shao J